ST LOUIS, Sept. 15 /PRNewswire/ -- CMS, Inc., an Elekta Company and worldwide leader in radiation treatment planning and workflow management solutions, today announced the commercial launch of its new 4D treatment planning solution, Focal4D(TM).
Focal4D, part of the Focal product line that also includes FocalSim and FocalPro, provides a comprehensive suite of capabilities that support the visualization and utilization of 4D image sets to create structures and review treatment options. With support for respiratory-correlated CT images, the robust toolset includes multiple viewing options such as cine and variable window formats and automated processes for creation of Internal Target Volumes.
"Focal4D provides a comprehensive suite of capabilities that support the visualization and utilization of 4D image sets to create structures and review treatment options. Its visualization and contouring tools help clinicians improve the planning process by taking into account how a patient's anatomy moves over time," says Jennifer Markham, Focal4D Product Manager. "With the ever-changing technology in Radiation Oncology, the opportunity to provide better patient care exists. By incorporating functionality to support this improved technology, Focal4D provides real solutions that address real clinical needs."
Focal4D joins the rest of the Focal product line as a key component in the comprehensive suite of radiation therapy planning tools offered by CMS. As CMS continues to develop cutting edge software to improve patient care, Focal4D is the next step in treatment planning for tumor motion.
CMS, Inc., an Elekta Company, is a worldwide market leader in radiation treatment planning and workflow management, combining innovative software applications and advanced technology tools to deliver comprehensive treatment planning and workflow management solutions that integrate seamlessly in any clinical environment. With a commitment to product excellence and a reputation for world-class service and support, CMS makes all members of the treatment team more effective in providing patient care.
CMS is part of the Elekta Group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight cancer and brain disorders.
With more than 2,500 employees globally, Elekta's corporate headquarters are located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information can be found at www.cmsrtp.com and www.elekta.com.
CONTACT: Michelle Lee, Elekta, Inc., +1-770-670-2447,
Web site: http://www.cmsrtp.com/